Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1

Interventions

Cytarabine 5Cyclophosphamide 4Clofarabine 4Vorinostat 3Sorafenib 3Arsenic Trioxide 3fludarabine phosphate 2Topotecan 2Lenalidomide 2Idarubicin 2Filgrastim 2Etoposide 2vadastuximab talirine 1tipifarnib 1tamibarotene 1romidepsin 1perifosine 1octadecyl-(N,N-dimethylpiperidino-4-yl)-phosphate 1ispinesib 1entinostat 1cyclo-tetrakis(bis(1-phenyl-3-methyl-4-benzoylpyrazolon-5-ato)mu-oxotitanium(IV)) 1belinostat 1Thiotepa 1Radiotherapy 1Methoxsalen 1Magnetic Resonance Spectroscopy 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Gadolinium 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Promyelocytic, Acute × Erythrocyte Transfusion × Clear all
NCT02086773 2019-01-24

Red Cell Transfusion Goals in Patients With Acute Leukemias

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
90 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡